Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05298904 · ClinicalTrials.gov registry record
Pro-active Genetic Testing in Kidney Transplant Patients
A clinical trial of Kidney Transplant, sponsored by Mayo Clinic.
- Active
- Registry status
- 177
- Enrollment target
- 1
- Study location
NCT05298904 is a study of Kidney Transplant that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 177 participants, below the 1,892-participant average among 30 other Kidney Transplant trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05298904, a study of Kidney Transplant, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- 177 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the prevalence of genetic mutations that increase the risk of cancer and other medically actionable diseases in kidney transplant patients and to assess the impact of genetic testing on subsequent surveillance for cancer.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Genetic Health Screen Panel
Study Locations (1)
Arizona
- Mayo Clinic Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2038-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05298904
The ClinicalTrials.gov registry entry for NCT05298904 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 177 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,892-participant average among 30 other Kidney Transplant trials with a reported enrollment target (91% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kidney Transplant appearing as the primary indexed condition, and to 1 intervention - of which Genetic Health Screen Panel is the first listed.
NCT05298904 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05298904 about?
NCT05298904 is a clinical study titled "Pro-active Genetic Testing in Kidney Transplant Patients". The purpose of this study is to determine the prevalence of genetic mutations that increase the risk of cancer and other medically actionable diseases in kidney transplant patients and to assess the impact of genetic testing on subsequent surveillance for cancer.
What is the current status of trial NCT05298904?
This trial is currently active not recruiting. The enrollment target is 177 participants. The study started on 2022-03-28. Estimated completion is 2038-03-01.
What conditions does trial NCT05298904 study?
This clinical trial studies the following conditions: Kidney Transplant.
What interventions are being tested in trial NCT05298904?
The interventions under investigation include: Genetic Health Screen Panel (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05298904?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05298904 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
Social Support Counseling Intervention for Kidney Transplant Candidates
RECRUITING · NA
-
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
RECRUITING · Phase 3
-
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
RECRUITING · Phase 3
-
Advancing Transplantation Outcomes in Children
RECRUITING · Phase 2
-
Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.